glp 1 pill GLP-1' Has Become an Empty Buzzword Clinically backed oral GLP FDA Approves New Weight Loss
Description
May 18, 2026/Heart, Vascular and Thoracic/Heart Failure & Transplant GLP-1 RAs Show Survival and Cardiovascular Benefits in Patients With HFrEF and Diabetes Large retrospective analysis may prompt prospective studies April 30, 2026/Ob/Gyn & Womens Health/Maternal-Fetal Medicine Preconception GLP-1 Use Not Linked to Higher Pregnancy Risk Data point to potential for targeted preconception planning April 10, 2026/Heart, Vascular and Thoracic/Vascular Medicine New Data Suggest GLP-1 Receptor Agonists Slow Abdominal Aortic Aneurysm Progression Robust signal from observational study raises prospect of a long-sought medical therapy March 30, 2026/Heart, Vascular and Thoracic/Preventive Cardiology Dual-Agonist Incretin Therapy Outshines GLP-1 Agonist in Broad Cardiorenal Outcomes Post hoc analysis of SURPASS-CVOT trial has implications for future cardiovascular outcome trials Advertisement Cleveland Clinic is a non-profit academic medical center
Impact of early SGLT2 inhibitors prescription on acute decompensated heart failure outcomes: insights from a real-world setting
SGLT2i: Sodium-glucose Cotransporter-2 inhibitors
doi: 10.1681/ASN.2019010064
Drug Type/Class 17.9.3
Is there evidence that medication-related anxiety resolves when the medication is adjusted or discontinued
